ROIVANT SCIENCES LTD. (ROIV)

SEC filing

ROIVANT SCIENCES LTD.

ROIV · CIK 1635088

4 · Dec 17, 2025 · Gline Matthew sold 1.74M shares at $21.68/share ($37.7M); exercised options for 3.87M shares; reported 2.13M shares

Gline Matthew sold 1.74M shares at $21.68/share ($37.7M); exercised options for 3.87M shares; reported 2.13M shares

FORM 4

xslF345X05/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).